This advert is not available!
The Department of Immunology, Genetics and Pathology at Uppsala University has a broad research profile with strong research groups focused on cancer, autoimmune and genetic diseases. A fundamental idea at the department is to stimulate translational research and thereby closer interactions between medical research and health care. Research is presently conducted in the following areas: cancer precision medicine, cancer immunotherapy, genomics and neurobiology, molecular tools and functional genomics, neuro-oncology and neurodegeneration and vascular biology. Department activities are also integrated with the units for Oncology, Clinical Genetics, Clinical Immunology, Clinical Pathology, and Hospital Physics at Akademiska sjukhuset, Uppsala. The department has teaching assignments in several education programmes, including Master Programmes, at the Faculty of Medicine, and at the Disciplinary Domain of Science and Technology. The department has a yearly turnover of around SEK 500 million, out of which more than half is made up of external funding. The staff amounts to approximately 345 employees, out of which 100 are PhD-students, and there are in total more than 700 affiliated people. Feel free to read more about the department's activities here: www.uu.se/en/staff/department/immunology-genetics-and-pathology
The Vickovic Lab at Uppsala University is seeking a dynamic, self-motivated, team-oriented Associate Computational Biologist or Statistician to expand computational efforts in understanding disease mechanisms. We are interested in developing integrative multi-modal data analysis tools incorporating single cell and spatially resolved omics data, imaging data, clinical phenotypes, variants and genotypes. The successful candidate will have the unique opportunity to work at the intersection of mathematical modeling, omics data analysis, workflow optimization, and resource building.
The Vickovic Lab is focused on developing novel “digital pathology” tools to track disease progression with the aim of identifying translatable drug and therapeutic targets in human tissue cohorts. The team leverages technologies including spatial transcriptomics, single-cell sequencing, and machine learning.
Duties
Responsibilities may include:
Requirements
Additional qualifications
Technical and Professional Skills: Consistently demonstrates skills and knowledge relevant for current role; strives to expand the depth and breadth of technical and professional skills; works with a high level of integrity; exhibits focus and discipline; appropriately prioritizes, manages expectations and delivers on commitments.
Collaborative & Communicative: Models collaboration and teamwork; brings out the best in others; effectively works with all levels, internally and externally; respects and embraces diversity of perspective; communicates clearly and listens carefully; uses good judgment as to what to communicate and when to do so.
Adaptable & Innovative: Adaptable and embraces change; develops new insights and pursues improvements and efficiency; fosters exchange of new ideas and willing to challenge the status quo; takes initiative and is solution-oriented; engages in work with passion and curiosity.
About the employment
The employment is a temporary position, 12 months. Scope of employment 100 %. Starting date as agreed. Placement: Uppsala
For further information about the position, please contact: Sanja Vickovic, sanja.vickovic@igp.uu.se
Please submit your application by June 25th 2024, UFV-PA 2024/1878.
Are you considering moving to Sweden to work at Uppsala University? Find out more about what it´s like to work and live in Sweden.
Type of employment | Temporary position |
---|---|
Contract type | Full time |
First day of employment | 2024-09-01 or as agreed |
Salary | Individual salary |
Number of positions | 1 |
Full-time equivalent | 100% |
City | Uppsala |
County | Uppsala län |
Country | Sweden |
Reference number | UFV-PA 2024/1878 |
Union representative |
|
Published | 10.Jun.2024 |
Last application date | 25.Jun.2024 11:59 PM CEST |